Affinity Technologies, Inc. ( ($BIAF) ) has issued an update. On October 16, 2025, bioAffinity Technologies, Inc. announced it received a ...

Affinity Technologies' stock surged after a patent notice and Nasdaq compliance update but slipped in after-hours trading.

Affinity Technologies, Inc. ( (BIAF) ) has issued an update. On October 15, 2025, bioAffinity Technologies announced it has regained compliance with Nasdaq’s listing requirements, ensuring its common ...

Personalis (PSNL) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase ...

Ingelheim, Germany / Ridgefield, Connecticut, U.S.Data from the Phase Ib Beamion LUNG-1 trial evaluating zongertinib in treatment-naïve patients ...

Data from the Phase Ib Beamion LUNG-1 trial evaluating HERNEXEOS® (zongertinib tablets) in treatment-naïve patients with advanced HER2 (ERBB2)-mutant ...

Rx, a digital medicine company specialising in pulmonary care, has announced the launch of pDx, a mobile and web-accessible ...

The bottom line: No, you can’t make up for lost training time and you don’t even have to try. Instead, ease back into running ...

A female infant presented with a month-long history of dry cough, along with two episodes of fever and increased work of ...

In CF, those with 2 ETI-responsive CTFR variants (vs 1 variant) are twice as likely to have sweat chloride concentrations on ETI within normal range.

High-profile mistakes have led to a loss in donor confidence. Experts say the system needs modernizing, not abandonment.

LONDON (Reuters) -German biotech firm Tubulis said on Wednesday it had raised 308 million euros ($358 million) in its biggest ...